1. Home
  2. BBNX

as of 03-11-2026 3:46pm EST

$10.94
$0.03
-0.27%
Stocks Health Care Medical/Dental Instruments Nasdaq

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Founded: 2015 Country:
United States
United States
Employees: 423 City: IRVINE
Market Cap: 493.1M IPO Year: N/A
Target Price: $26.22 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $8.89 - $32.71 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 34.99% Revenue Growth (next year): 34.47%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: